Detection of SARS-CoV-2 infection prevalence in 860 cancer patients with a combined screening procedure including triage, molecular nasopharyngeal swabs and rapid serological test. A report from the first epidemic wave심사, 분자 비 인두 면봉 및 빠른 혈청 학적 검사를 포함한 선별 검사 절차를 가진 860 명의 암 환자에서 SARS-COV-2 감염 유병률의 검출.첫 번째 전염병 파의 보고서Research Article Published on 2022-02-022022-09-10 Journal: PLoS ONE [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, [키워드] adopted anti-cancer therapies anti-SARS-CoV-2 anticancer Asymptomatic Asymptomatic cases balance Cancer cancer patient Cancer patients circulation consecutive patients COVID-19 detect detection diagnostic dose intensity effective Efficacy entity epidemic curve epidemic wave evaluate evaluated feasibility First wave hematologic IgG/IgM antibodies IgM antibodies immunoassay immunologic response Infection Intensive knowledge less lockdown measure Measures molecular Nasopharyngeal swab neoplastic NPs Outpatient Patient patient population performed positive Prevalence primary endpoint questionnaire receiving recommendation reduction SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 pandemic screening procedure self-reported symptom Self-reported symptoms serologic test serological serological test Serological tests solid tumors Symptom tested the epidemic the patient the SARS-CoV-2 therapy Triage tumors vaccination weapon [DOI] 10.1371/journal.pone.0262784 PMC 바로가기 [Article Type] Research Article
Persistence of Anti-SARS-CoV-2 Antibodies in Long Term Care Residents Over Seven Months After Two COVID-19 Outbreaks두 번의 COVID-19 발생 후 7개월 동안 장기 요양 시설 입소자의 항 SARS-CoV-2 항체 지속성Immunology Published on 2022-01-032022-09-11 Journal: Frontiers in Immunology [Category] MERS, 진단, 치료법, [키워드] 229E Analysis Anti-nucleocapsid antibodies anti-nucleocapsid antibody Anti-spike antibody antibody levels approved attack rate binding domain Canada Care carried changes in collected comparison COVID-19 COVID-19 outbreak cross reaction demonstrated evaluate finding Gradual HCoV HCoV-229E HCoV-HKU1 HCoV-NL63 HCoV-OC43 HKU1 human coronavirus human coronavirus (HCoV) humoral humoral immune response Humoral response humoral responses individual individuals Long long term Long term care facilities median MONITOR monitors Month multiplexed immunoassay NL63 nucleocapsid OC43 outbreak Outbreak investigation outbreak investigations Outbreaks over participant participated performed platform provided public health RBD reaction Receptor binding domain Reinfection resident SARS-CoV-2 serologic test serologic testing serologic tests serological serological survey Serological surveys seronegative seropositive seropositive individual serostatus serum serum sample serum samples Seven Spike protein Spike proteins statistical analyses statistically significant survey term the spike protein were used [DOI] 10.3389/fimmu.2021.775420 PMC 바로가기 [Article Type] Immunology
Serologic response to COVID-19 infection and/or vaccine in cancer patients on active treatment활성 치료 중인 암 환자의 COVID-19 감염 및/또는 백신에 대한 혈청학적 반응Article Published on 2021-12-012022-09-11 Journal: ESMO open [Category] SARS, 변종, 치료법, [키워드] active treatment anti-S Anti-S1 antibody antibody response rate Antibody titer biologic BNT162b2 BNT162b2 mRNA BNT162b2 mRNA COVID-19 vaccine booster Cancer cancer patient Cancer patients Chemotherapy Chemotherapy treatment Cohort control group COVID-19 COVID-19 infection COVID-19 vaccination COVID-19 vaccine COVID-19 vaccines domain dose evaluated Health care Health care worker humoral identify Immunocompromised Immunocompromised patient Immunocompromised patients immunogenic immunogenicity Immunologic immunologic response Immunotherapy Infection less metastatic disease multiple regression model natural infection Neutralizing antibody titer Odds ratio other treatment other treatments Patient positive positive response reduced response rate S1/S2 SARS-CoV-2 variant SARS-CoV-2 variants serologic Serologic response serologic test serologic tests serological surveillance shown significantly solid tumor solid tumors Specific subgroup subgroups the SARS-CoV-2 Treatment tumors vaccination Vaccine vaccine doses Virological were measured [DOI] 10.1016/j.esmoop.2021.100283 PMC 바로가기 [Article Type] Article
CAN IgG ANTIBODIES DIRECTED AGAINST DIFFERENT TARGETS SOLVE THE PROBLEM OF FALSE-POSITIVE RESULTS IN SARS-CoV-2 SEROLOGY?다른 표적에 대한 IgG 항체가 SARS-CoV-2 혈청학에서 위양성 결과의 문제를 해결할 수 있습니까?Article Published on 2021-12-012022-09-12 Journal: Acta clinica Croatica [Category] SARS, 진단, [키워드] addition Anti- SARS-CoV-2 IgG antigens cross-reactivity ELFA ELISA False-positive results France global pandemic IgG Infection Italy medium observation offer other coronavirus Patient positive Positive predictive value positive result RT-PCR assays SARS-CoV SARS-CoV 2 SARS-CoV-2 SARS-COV-2 infection serologic test serologic tests serology serology test serology testing Spread tested [DOI] 10.20471/acc.2021.60.04.25 PMC 바로가기 [Article Type] Article
Combined presentation of severe pulmonary COVID-19 and multisystem inflammatory syndrome in children (MIS-C): two reported Egyptian pediatric casesCase Report Published on 2021-12-012022-10-31 Journal: Egyptian Pediatric Association Gazette [Category] COVID-19, [키워드] acute respiratory syndrome addition Adults children clinical criteria Clinical finding Combined conditions coronavirus coronavirus disease COVID-19 criteria Critical debatable described Diagnosis discharged disorder Egypt favor Fever Follow-up Inflammatory Inflammatory marker less Lung CT manifestation MIS-C pandemic Patient patients with SARS-CoV-2 PCR pediatric Pediatric case positive presenting Prognosis pulmonary pulmonary symptoms reported risk SARS-CoV-2 serologic test starting steroid susceptible syndrome therapy Treatment Two patient unique [DOI] 10.1186/s43054-021-00076-w PMC 바로가기 [Article Type] Case Report
COVID-19 Antibody Detection and Assay Performance Using Red Cell AgglutinationConference abstract Published on 2021-11-232022-10-05 Journal: Blood [Category] 치료기술, [키워드] acute respiratory syndrome agglutination anti-SARS-CoV-2 anti-SARS-CoV-2 IgG antibodies antibody antibody concentration assays AUC Blood CCP Cell Clinical course clinical evaluation coated with collected commercial immunoassay Concentration convalescent plasma coronavirus correlation COVID-19 COVID-19 disease COVID-19 outbreak current detect detection Donor donors EUA FDA Follow-up healthy hospital IgA IgG IgM IMPROVE Laboratory Longitudinal data Neutralizing nucleocapsid protein peptide performance performed plasma sample plasma samples positive Prognosis ranged Rapid test reached Red Red cell required resource ROC Curve SARS-CoV-2 sensitivity serologic serologic test serology tests Spearman Specificities specificity Spike protein suggested tested Testing the SARS-CoV-2 Total virus was measured was performed was tested [DOI] 10.1182/blood-2021-150795 [Article Type] Conference abstract
Neutralizing antibody responses following natural SARS-CoV-2 infection: Dynamics and correlation with commercial serologic tests자연적인 SARS-CoV-2 감염에 따른 중화 항체 반응: 상업적 혈청학적 검사와의 역학 및 상관관계Article Published on 2021-11-012022-09-11 Journal: Journal of Clinical Virology [Category] MERS, SARS, 진단, 치료기술, 치료법, [키워드] allocation anti-SARS-CoV-2 Anti-spike Antibody Response Antibody titer Antibody titers assays booster doses correlation COVID-19 cross-reactivity demonstrated detect diagnostic domain Dynamics Efficacy Elecsy Elecsys ELISA Euroimmun evaluate evaluated except for facilitate Follow-up healthcare worker IgG immunoassay immunoassays long term MONITOR NAbs Neutralizing antibodies Neutralizing antibody response neutralizing capacity participant participated performed plaque reduction neutralization Post-vaccine Protein reference standard SARS-CoV-2 SARS-CoV-2 IgG SARS-CoV-2 immunity SARS-COV-2 infection SARS-CoV-2 neutralizing antibodies sera serologic test serologic tests seronegative seroprevalence survey significant decrease Support the immunoassay total antibodies vaccination [DOI] 10.1016/j.jcv.2021.104988 PMC 바로가기 [Article Type] Article
Competitive ELISA for a serologic test to detect dengue serotype-specific anti-NS1 IgGs using high-affinity UB-DNA aptamersArticle Published on 2021-09-092022-10-04 Journal: Scientific Reports [Category] 진단, [키워드] Antigen antigen-detection Biological techniques blood sample Care Combination cross-reactivity detect develop Diagnostic method diagnostics Diseases DNA ELISA enzyme-linked immunosorbent facilitate identify IgG Infection inhibited Patient plasma sample positive Protein recognize reflected sandwich ELISA serologic test serotype serotype-specific serotypes Specificities unique Vaccine development viral infection Zika [DOI] 10.1038/s41598-021-97339-8 PMC 바로가기 [Article Type] Article
COVID-19 clinical and laboratory diagnosis overviewReview Published on 2021-08-182022-10-30 Journal: Journal of the Egyptian Public Health Association [Category] COVID-19, [키워드] 2019-nCoV adopted approach clinical clinical decision clinical suspicion Community COVID-19 COVID-19 diagnosis COVID-19 infection Diagnosis diagnostics drastic false-negative Genetic global pandemic Isolation lab Laboratory measure novel corona virus outbreak PCR testing raise raised reported risk RT-PCR RT-PCR diagnosis RT-PCR kit SARS-CoV-2 sequence serologic test serological serology Spread therapeutic intervention Wuhan, China [DOI] 10.1186/s42506-021-00087-w PMC 바로가기 [Article Type] Review
SARS-CoV-2 Infection among Medical Institution Faculty and Healthcare Workers in Tokyo, Japan일본 도쿄의 의료 기관 교수진 및 의료 종사자 중 SARS-CoV-2 감염Article Published on 2021-08-152022-09-11 Journal: Internal medicine (Tokyo, Japan) [Category] SARS, 치료기술, [키워드] 95% CI 95% confidence interval acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 analyzed antibody antibody-positive result Care Clinical characteristics coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 patient demographic and clinical characteristics detect dysgeusia dysosmia effective evaluated faculty Fever Frequency greater HCW HCWs healthcare worker Healthcare workers Immunoglobulin Immunoglobulin G Infection infection rate institution Japan material measure Medical care Mild no significant difference objective occurred participant positive positive test result precautions recruited reduce Result risk of COVID-19 SARS-CoV-2 SARS-COV-2 infection serologic test serologic tests severe acute respiratory syndrome Coronavirus significant difference Spread the SARS-CoV-2 Tokyo worker [DOI] 10.2169/internalmedicine.7033-21 PMC 바로가기 [Article Type] Article